Search | IOVS | ARVO Journals

Showing 1 – 20 of 39

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Functional I n Silico Analysis of Human Tyrosinase and OCA1 Associated Mutations

Milan Patel; Claudi Kassouf; Yuri V Sergeev

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5010. doi:

ARVO Annual Meeting Abstract June 2020

Isolation of DOPAchrome by characterizing and utilizing Tyrosinase bound Ni-NTA Magnetic Beads

Paul Varghese; Yuri V Sergeev; Emilios Dimitriadis; George Morcos; Monika Dolinska

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5022. doi:

ARVO Annual Meeting Abstract July 2019

Title: Human Tyrosinase: Temperature-dependent Estimation of Gibbs Energies of Oxidase Activity

Kenneth Lee Young II; Claudia Kassouf; Monika Dolinska; David Anderson; Yuri V. Sergeev

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5684. doi:

ARVO Annual Meeting Abstract July 2019

Molecular modeling and global computational mutagenesis of ABCA4 protein show a role of missense changes in Stargardt’s disease.

Yuri V Sergeev; Kaoru Fujinami; Benedetto Falsini; Wadih M Zein; Kerry Goetz; Yu Yokokawa Fujinami; Se Joon Woo; Shiying Li; Matteo Bertelli; Winston Lee; Jana Zernant; Rando Allikmets; Andrew Webster; Michel Michaelides; Brian Patrick Brooks; Paul A Sieving

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3872. doi:

ARVO Annual Meeting Abstract July 2019

NEI Ocular Proteome Database: A Description of Inherited Eye Disease Proteins and Their Stability Changes by a Computational Global Mutagenesis.

Claudia Kassouf; Caitlyn McCafferty; Yuri V Sergeev; Francisca Wood Ortiz

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):386. doi:

ARVO Annual Meeting Abstract July 2018

The Tyrp1 protection of human tyrosinase activity do not involve interaction between tyrosinase domains.

Monika Barbara Dolinska; Kenneth Young; Paul Wingfield; Brian Patrick Brooks; Yuri Sergeev

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2359. doi:

ARVO Annual Meeting Abstract July 2018

Global computational mutagenesis of ocular proteome indicates a role of protein destabilization in inherited eye disease.

Yuri Sergeev; Francisca Wood Ortiz; Mikhail Laryukhin; Caitlyn McCafferty

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2365. doi:

ARVO Annual Meeting Abstract June 2017

Frequent hypomorphic alleles solve 80% of late-onset ABCA4 disease and distinguish it from age-related macular degeneration

Rando Allikmets; Jana Zernant; Frederick T Collison; Gerald A Fishman; Yuri V Sergeev; Kaspar Schuerch; Janet R Sparrow; Stephen Tsang; Winston Lee

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1240. doi:

ARVO Annual Meeting Abstract June 2017

βA3/A1-Crystallin/SLC36A4/V-ATPase complex in the RPE is a novel therapeutic target for AMD

Peng Shang; Mallika Valapala; Stacey L Hose; Jun Wan; Jiang Qian; Yuri V Sergeev; J. Samuel Zigler, Jr.; Debasish Sinha

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3384. doi:

ARVO Annual Meeting Abstract June 2017

Purification and Characterization of Recombinant Human Tyrosinase Related Protein 1

Kenneth Lee Young II; Monika Dolinksa; Paul Wingfield; Eugenia Poliakov; Yuri V Sergeev

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):626. doi:

ARVO Annual Meeting Abstract September 2016

The National Eye Institute Prospective ABCA4 Retinopathy Natural History Study: Autofluorescence Imaging Analysis

Laryssa Huryn; Brett G Jeffrey; Aarti Hinduja; Catherine A Cukras; Wadih M Zein; Robert B Hufnagel; Yuri V Sergeev; Benedetto Falsini; Amy Turriff; Denise Cunningham; Brian Patrick Brooks

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):140. doi:

ARVO Annual Meeting Abstract September 2016

A Computational Analysis of Human Tyrosinase to Further Understanding of Oculocutaneous Albinism Type 1

Katie Farney; Monika B Dolinska; Yuri V Sergeev

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):670. doi:

ARVO Annual Meeting Abstract September 2016

Purification and biochemical characterization of full-length human tyrosinase

Nicole Joanne Kus; Monika B Dolinska; Yuri V Sergeev

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1723. doi:

ARVO Annual Meeting Abstract September 2016

Unfolding mutation screen for inherited eye disease

Caitlyn McCafferty; Yuri V Sergeev

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3162. doi:

ARVO Annual Meeting Abstract September 2016

In-silico unfolding: a role of missense changes in Stargardt’s disease.

Yuri V Sergeev; Caitlyn McCafferty; Kaoru Fujinami; Benedetto Falsini; Wadih M Zein; Kanishka Thiran Jayasundera; Michel Michaelides; Brian Patrick Brooks; Paul A Sieving

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3163. doi:

ARVO Annual Meeting Abstract June 2015

Stargardt ABCA4 mutation analysis in trans-membrane and nucleotide-binding domains

Yuri V Sergeev; Katherine Pogrebniak; Kaoru Fujinami; Benedetto Falsini; Wadih M Zein; Kerry E Goetz; Thiran Jayasundera; Michel Michaelides; Brian Patrick Brooks; Paul A Sieving

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2860. doi:

ARVO Annual Meeting Abstract June 2015

Identification of heterotypic rox sites for use in novel Dre recombination strategies

Eileen Nguyen; Katherine Chuang; Yuri V Sergeev; Tudor Badea

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4664. doi:

ARVO Annual Meeting Abstract June 2015

Oculocutaneous albinism Type 1 mutations indicate changes in the recombinant tyrosinase folding and activity.

Monika B Dolinska; Paul T Wingfield; Sara Farney; Brian Patrick Brooks; Yuri V Sergeev

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4665. doi:

ARVO Annual Meeting Abstract June 2015

Novel compound heterozygous mutations of Leber congenital amaurosis in CCT2

Yuriko Minegishi; XunLun Sheng; Kazuho Ikeo; Yuri V Sergeev; Takeshi Iwata

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5424. doi:

ARVO Annual Meeting Abstract April 2014

AMD-associated Sequence Variants Encode Conserved SUSHI Domains in Complement Proteins

John Paul P SanGiovanni; Traci E Clemons; Emily Y Chew; Yuri V Sergeev

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):631. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Functional I n Silico Analysis of Human Tyrosinase and OCA1 Associated Mutations

Isolation of DOPAchrome by characterizing and utilizing Tyrosinase bound Ni-NTA Magnetic Beads

Title: Human Tyrosinase: Temperature-dependent Estimation of Gibbs Energies of Oxidase Activity

Molecular modeling and global computational mutagenesis of ABCA4 protein show a role of missense changes in Stargardt’s disease.

NEI Ocular Proteome Database: A Description of Inherited Eye Disease Proteins and Their Stability Changes by a Computational Global Mutagenesis.

The Tyrp1 protection of human tyrosinase activity do not involve interaction between tyrosinase domains.

Global computational mutagenesis of ocular proteome indicates a role of protein destabilization in inherited eye disease.

Frequent hypomorphic alleles solve 80% of late-onset ABCA4 disease and distinguish it from age-related macular degeneration

βA3/A1-Crystallin/SLC36A4/V-ATPase complex in the RPE is a novel therapeutic target for AMD

Purification and Characterization of Recombinant Human Tyrosinase Related Protein 1

The National Eye Institute Prospective ABCA4 Retinopathy Natural History Study: Autofluorescence Imaging Analysis

A Computational Analysis of Human Tyrosinase to Further Understanding of Oculocutaneous Albinism Type 1

Purification and biochemical characterization of full-length human tyrosinase

Unfolding mutation screen for inherited eye disease

In-silico unfolding: a role of missense changes in Stargardt’s disease.

Stargardt ABCA4 mutation analysis in trans-membrane and nucleotide-binding domains

Identification of heterotypic rox sites for use in novel Dre recombination strategies

Oculocutaneous albinism Type 1 mutations indicate changes in the recombinant tyrosinase folding and activity.

Novel compound heterozygous mutations of Leber congenital amaurosis in CCT2

AMD-associated Sequence Variants Encode Conserved SUSHI Domains in Complement Proteins

To View More...

You must be signed into an individual account to use this feature.